Literature DB >> 2263891

Epidemiologic control of genital Chlamydia trachomatis infections.

T Ripa1.   

Abstract

Sexually transmitted diseases (STD), whether old or new, impose a heavy economic burden on the public health service. Behavioural changes that could reduce the incidence of STD in the general population take time to make their effects felt. Common and treatable diseases such as genital chlamydial infections can and should be tackled by the old familiar strategy for combatting STD, viz. case finding, diagnosis, contact tracing and treatment, parallel with counselling in sexual behaviour. The incidence of infection is largely dependent on the number of asymptomatic individuals with a chlamydial infection in the population. Case finding programs devised chiefly for young, sexually active people will thus directly influence the natural life of Chlamydia trachomatis in our society. One such program, involving the sampling of women below the age of 30 when they come to the family planning clinic (FPC) for contraceptive advice, when applying for legal abortion, or when receiving prenatal care has been running in Halmstad, with increasing effect, since 1982. Contact tracing is an important part of the program. The prevalence of infected women has been halved since 1984 in the age interval 15-29 years. 10% of infected females, 15-24 years old, evidence repeated infection during 1 year. This program, carried out at a FPC, has proved cost-effective, achieving a 44% reduction in calculated expenditure. Chlamydial infections in Sweden are changing in character from being an untreated hyperendemic disease up to the late 1970s, to become a treated hyperendemic disease, until at last a declining prevalence can now be discerned.

Entities:  

Mesh:

Year:  1990        PMID: 2263891

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  21 in total

Review 1.  Dysuria in adolescents.

Authors:  H Claudius
Journal:  West J Med       Date:  2000-03

Review 2.  Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.

Authors:  E Honey; C Augood; A Templeton; I Russell; J Paavonen; P-A Mårdh; A Stary; B Stray-Pedersen
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

3.  Chlamydial infection in Canada.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

Review 4.  Screening programmes for chlamydial infection: when will we ever learn?

Authors:  Nicola Low
Journal:  BMJ       Date:  2007-04-07

5.  Screening for chlamydial infection. Taking stock.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

Review 6.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

7.  Plasmid carriage and antibiotic susceptibility of Neisseria meningitidis strains isolated in Sweden 1981-1990.

Authors:  A Bäckmann; D Danielsson; P Olcén
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

8.  Risk factors for genital chlamydial infection.

Authors:  Christine Navarro; Anne Jolly; Rama Nair; Yue Chen
Journal:  Can J Infect Dis       Date:  2002-05

9.  Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary.

Authors:  T Nyári; J Deák; E Nagy; I Veréb; L Kovács; G Mészáros; H Orvos; I Berbik
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

Review 10.  Vaccines for bacterial sexually transmitted infections: a realistic goal?

Authors:  P F Sparling; C Elkins; P B Wyrick; M S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.